Michael Man‐Chu Lo
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Hormonal Regulation and Hypertension, Nitric Oxide and Endothelin Effects, Pharmacogenetics and Drug Metabolism, Crystallography and molecular interactions, Receptor Mechanisms and Signaling
Most-Cited Works
- → Novel Pyridyl- or Isoquinolinyl-Substituted Indolines and Indoles as Potent and Selective Aldosterone Synthase Inhibitors(2014)55 cited
- → Discovery of [11C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases(2020)39 cited
- → Novel Pyridyl Substituted 4,5-Dihydro-[1,2,4]triazolo[4,3-a]quinolines as Potent and Selective Aldosterone Synthase Inhibitors with Improved in Vitro Metabolic Stability(2015)26 cited
- → Discovery and Clinical Evaluation of MK‐8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release(2016)15 cited
- → Calcium Dialkylamine Diazeniumdiolates: Synthesis, Stability, and Nitric Oxide Generation(2020)12 cited
- → Imidazopyridyl compounds as aldosterone synthase inhibitors(2016)10 cited
- → Highly Diastereoselective Access to Densely Functionalized Piperidine Cores of Influenza Endonuclease Inhibitors via a Metal-Free SN1 Approach(2025)
- Applications of C₂-symmetric bis(azaferrocenes) in asymmetric copper-catalyzed reactions(2002)
- → CCDC 1015605: Experimental Crystal Structure Determination(2014)
- → CCDC 1015606: Experimental Crystal Structure Determination(2014)